EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor‐Negative Breast Cancer

Suad A K Shamis iD, Jean Quinn, Sara Al-Badran, Molly McKenzie, Phimmada Hatthakarnkul, Gerard Lynch, Guang-Yu Lian, Warapan Numprasit, Laszlo Romics, Ditte Andersen, Elizabeth Mallon, Donald C McMillan und 1 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Suad A K Shamis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Surgery, School of Medicine, University of Glasgow, Royal Infirmary, Glasgow, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Carbonic Anhydrase IX, Receptors, Estrogen, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Carbonic anhydrase IX (CAIX) is a well‐established prognostic marker in breast cancer (BC). Nevertheless, this prognostic value is yet to be confirmed in BC subtypes. This study aims to investigate the prognostic effects of CAIX in oestrogen receptor (ER)‐negative (ER−) BCs and to establish pathways related to cytoplasmic CAIX expression in ER− and lymph node‐negative BCs.

Methods

Immunohistochemistry was performed to identify the prognostic role of CAIX protein expression in ER− tissue microarrays (TMAs) ( n = 191). CAIX‐positive samples ( n = 37) were transcriptionally profiled by TempO‐Seq and analysed by STRING. Real‐time quantitative PCR (RT‐qPCR) analysis was used to validate differentially expressed genes.

Results

Overexpression of cytoplasmic CAIX was an independent predictor of recurrence free survival, disease‐free survival and overall survival in ER− cohort. RNA transcriptomic analysis identified 10 significant genes in ER− cohort and 3 genes in the node‐negative group. The STRING database demonstrated a significant interaction between MUCL1 and GALNT6, which were linked with extracellular matrix organisation, degradation of the extracellular matrix and disease of glycosylation pathways. In the node‐negative group, SPNS2 is mainly involved in the sphingolipid de novo biosynthesis pathway. A significant correlation between cytoplasmic SphK1 and cytoplasmic hypoxia‐inducible factor‐1α was observed. Among the 10 genes, 7 genes (SERHL2, GALNT6, MUCL1, MMP7, PITX2, CEACAM6 and SPNS2) were selected, and their expression was quantitatively assessed by RT‐qPCR. The PCR data of these genes showed that SERHL2, GALNT6, MUCL1, PITX2, and SPNS2 mRNA levels were expressed in MDA‐MB‐231 BC cell lines at variable levels of hypoxic exposure.

Conclusion

Cytoplasmic CAIX was independently associated with poor prognosis in ER− BC. Gene expression profiles shed light on the pathways and genes associated with hypoxia in ER− BC. In node‐negative patients, SPNS2 was of particular interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarbonic Anhydrase IXReceptors, EstrogenGene Expression Regulation, NeoplasticHumansFemalePrognosisMiddle AgedBiomarkers, TumorGene Expression ProfilingAgedAntigens, Neoplasm

Stichwörter der Autor:innen

RNA sequencingbreast cancercarbonic anhydrases IXhypoxiasurvival

Substanzen

Carbonic Anhydrase IXReceptors, EstrogenBiomarkers, TumorCA9 protein, humanAntigens, Neoplasm

Autor:innen und Institutionen

  • Academic Unit of Surgery, School of Medicine, University of Glasgow, Royal Infirmary, Glasgow, UK.
  • Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • NHS Greater Glasgow and Clyde (New Victoria Hospital), Glasgow, UK.
  • BioClavis Ltd., Teaching & Learning Centre, Queen Elizabeth University Hospital, Glasgow, UK.
  • Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.

ORCID-Profile: Suad A K Shamis

Zitieren

APA

Shamis, S. A. K., Quinn, J., Al-Badran, S., McKenzie, M., Hatthakarnkul, P., Lynch, G., Lian, G. Y., Numprasit, W., Romics, L., Andersen, D., Mallon, E., McMillan, D. C., & Edwards, J. (2024). Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor‐Negative Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70274

Vancouver

Shamis SAK, Quinn J, Al-Badran S, McKenzie M, Hatthakarnkul P, Lynch G, et al. Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor‐Negative Breast Cancer. Cancer Medicine. 2024. doi:10.1002/cam4.70274

BibTeX
@article{Shamis2024,
  author = {Shamis, Suad A K and Quinn, Jean and Al-Badran, Sara and McKenzie, Molly and Hatthakarnkul, Phimmada and Lynch, Gerard and Lian, Guang-Yu and Numprasit, Warapan and Romics, Laszlo and Andersen, Ditte and Mallon, Elizabeth and McMillan, Donald C and Edwards, Joanne},
  title = {Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor‐Negative Breast Cancer},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70274}
}
Kostenlos starten →